Found 18 matching trials
Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy Subjects
PHASE1To evaluate the effect of oral itraconazole on the pharmacokinetics of SHR0...
Location
The Third Hospital of Changsha
Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy
PHASE2The purpose of this study is to evaluate the efficacy and safety of SHR1459...
Location
The First Affiliated Hospital of Anhui Medical University
Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients
PHASE1Condition: Rheumatoid Arthritis Intervention: Drug: SHR0302; Drug: SHR0302 ...
Location
Peking Union Medical College Hospital
Study on the Bioavailability of SHR0302 in Healthy Subjects
PHASE1The study is being conducted to evaluate the safety, and the relative bioav...
Location
Xuanwu Hospital Beijing,Capital Medical University
A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.
PHASE2The proposed study is a randomized, double-blind,placebo-controlled, multic...
Location
Wellness Clinical Research, LLLC-Central Florida
Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects
PHASE1The purpose of this open-label, randomized, two-period, two-treatment (sing...
Location
Shanghai Xuhui Central Hospital
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
PHASE3This is a randomized, double-blind, placebo-controlled, multicenter Phase 3...
Location
Digestive Health Specialists
A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo
PHASE2The study is being conducted to evaluate the efficacy, and safety of SHR030...
Location
Dermatology Hospital affiliated to Shandong First Medical University
First-in-Human Single Ascending Dose of SHR0302
PHASE1The purpose of the study is to evaluate the safety and tolerability of sing...
Location
First Affiliated Hospital of Fourth Military Medical University
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
PHASE3This is a randomized, double-blind, placebo-controlled, multicenter Phase 3...
Location
Dermatology Research Institute Inc.